Avastin and Thiotepa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Avastin and Thiotepa. Common interactions include disease progression among females and death among males.

The phase IV clinical study analyzes what interactions people who take Avastin and Thiotepa have. It is created by eHealthMe based on reports of 12 people who take Avastin and Thiotepa from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 28, 2022

12 people who take Avastin and Thiotepa together, and have interactions are studied.


What is Avastin?

Avastin has active ingredients of bevacizumab. It is often used in macular degeneration. eHealthMe is studying from 66,231 Avastin users for its effectiveness, alternative drugs and more.

What is Thiotepa?

Thiotepa has active ingredients of thiotepa. eHealthMe is studying from 5,956 Thiotepa users for its effectiveness, alternative drugs and more.

Number of Avastin and Thiotepa reports submitted per year:

Avastin and Thiotepa drug interactions.

Common Avastin and Thiotepa drug interactions by gender *:

female:

  1. Disease progression
  2. Death
  3. Fatigue
  4. Nausea
  5. Pyrexia
  6. Contusion
  7. Depression
  8. Dizziness
  9. Erythema
  10. Fall

male:

  1. Death
  2. Acne
  3. Metastases to lung
  4. Metastases to meninges
  5. Visual acuity reduced
  6. Cerebral hypoperfusion
  7. Cough
  8. Dermatitis
  9. Dilatation ventricular
  10. Eating disorder

Common Avastin and Thiotepa drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Death
  2. Fatigue
  3. Metastases to lung
  4. Metastases to meninges
  5. Visual acuity reduced
  6. Contusion
  7. Depression
  8. Disease progression
  9. Dizziness
  10. Erythema

50-59:

n/a

60+:

n/a

Common conditions people have *:

  1. Drug Dependence: 6 people, 50.00%
  2. Breast Cancer Female: 3 people, 25.00%
  3. Lung Neoplasm Malignant (cancer tumour of lung): 2 people, 16.67%
  4. Haematological Malignancy (cancer that affect blood, bone marrow, and lymph nodes): 2 people, 16.67%
  5. Ovarian Cancer (cancer of ovary): 1 person, 8.33%
  6. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Avastin and Thiotepa?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Avastin and Thiotepa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Avastin interactions:

Browse all interactions between Avastin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Thiotepa interactions:

Browse all interactions between Thiotepa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on bevacizumab and thiotepa (the active ingredients of Avastin and Thiotepa, respectively), and Avastin and Thiotepa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: